«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

27卷

期数:

2021年04期

页码:

384-387

栏目:

临床医学

出版日期:

2021-07-20

文章信息/Info

Title:

Effect of perioperative enteral and parenteral nutrition on rapid recovery of patients after hepatectomy

文章编号:

1006－8147（2021）04-0384-04

作者:

陈莹¹; 张雅敏²

（1.天津市职业病防治院（工人医院）普通外科，天津 300011；2天津市第一中心医院肝胆外科，天津 300192）

Author(s):

CHEN Ying¹; ZHANG Ya-min²

（1.Department of General Surgery，Tianjin Occupational Disease Prevention and Control Hospital（Workers′ Hospital），Tianjin 300011，China；2.Department of Hepatobiliary Surgery, Tianjin First Central Hospital，Tianjin 300192，China）

关键词:

肝癌; 肝切除术;  肠内营养; 肠外营养; 围手术期; 肝功能

Keywords:

liver cancer; liver resection; enteral nutrition; parenteral nutrition; perioperative; liver function

分类号:

R657.3

DOI:

-

文献标志码:

A

摘要:

目的：探讨新型橄榄油脂肪乳肠外营养联合肠内营养对肝切除术后恢复的作用。方法：收集2018年12月—2020年2月天津市第一中心医院拟行肝切除的肝细胞癌患者48例。随机分为试验组（n=24）和对照组（n=24）。试验组术前3 d给予口服肠内营养混悬剂TP-MCT，术后前3 d静脉输入新型橄榄油脂肪乳联合术后早期给予肠内营养混悬剂TP-MCT；对照组术前给予自由肠内营养，术后前3 d静脉输入大豆油长链脂肪乳的配制型肠外营养液联合术后早期给予口服肠内营养混悬剂TP-MCT。比较两组术前一般指标，术后并发症、营养状况、肝功能、体液、细胞免疫及炎症因子水平改变。结果：试验组和对照组在恶心呕吐、腹泻及术后并发症总发生率上的差异有统计学意义（?字2=3.122、4.415、4.761，均P＜0.05）。试验组术后7 d体重指数（BMI）和皮脂厚度均高于对照组（t=2.860，P＜0.05）；术后第3天和第7天，试验组血清白蛋白水平及前白蛋白明显高于对照组（t=3.652、4.150，均P＜0.05）。试验组与对照组术后第1天乳酸脱氢酶（LDH）、直接胆红素（DBIL）、活化部分凝血酶原时间（APTT）存在差异性（t=2.312、3.165、4.178，均P＜0.05）；术后第3天及第7天，谷草转氨酶（AST）、谷丙转氨酶（ALT）、LDH、DBIL、间接胆红素（IBIL）、APPT（t=1.450～6.152，均P＜0.05）。术后第3天CD4+、CD8+T细胞在试验组中比例下降低于对照组（?字2=5.750，P＜0.05）。结论：应用新型橄榄油脂肪乳肠外营养联合肠内营养减少术后并发症的发生，耐受性良好，有助于营养状况、肝功能指标、细胞免疫、体液免疫及炎症因子水平的恢复。

Abstract:

Objective: To investigate the effect of new olive oil fat emulsion parenteral nutrition combined with enteral nutrition on the recovery after hepatectomy. Methods: A total of 48 patients with hepatocellular carcinoma who were admitted to Tianjin First Central Hospital from December 2018 to February 2020 for hepatectomy were collected. They were randomly divided into experimental group（n=24） and control group（n=24）. The experimental group was given oral enteral nutrition suspension TP-MCT 3 days before operation， intravenous injection of new olive oil fat emulsion combined with early postoperative enteral nutrition suspension TP-MCT 3 days after operation; the control group was given free enteral nutrition before operation， intravenous injection of soybean oil long chain fat emulsion combined with early postoperative oral enteral nutrition suspension TP-MCT 3 days before operation. The general indexes，postoperative complications， nutritional status， liver function， humoral and cellular immunity and inflammatory factors were compared between the two groups. Results: There were significant differences in the incidence of nausea， vomiting， diarrhea and postoperative complications between the experimental group and the control group（?字2=3.122，4.415，4.761，all P<0.05）. The body mass index（BMI） and sebum thickness of the experimental group were higher than those of the control group on the 7th day after operation（t=2.860，P<0.05）；the serum albumin level and prealbumin of the experimental group were significantly higher than those of the control group on the 3rd and 7th day after operation（t=3.65，24.150，both P<0.05）. There were significant differences in LDH， DBIL and APTT between the experimental group and the control group on the first day after operation（t=2.312，3.165，4.178，all P<0.05）；there were significant differences in AST， ALT， LDH， DBIL， IBIL and APTT on the third and seventh day after operation（t=1.450-6.152，all P<0.05）. On the third day after operation， the proportion of CD4+ and CD8+ T cells in the experimental group was lower than that in the control group（?字2=5.750，P<0.05）. Conclusion: The application of new olive oil fat emulsion for parenteral nutrition combined with enteral nutrition in perioperative period can reduce the incidence of postoperative complications and is well tolerated. The patients′ humoral immune function， humoral immune function and immune factors are improved.

参考文献/References:

[1] 王峪，刘懿禾，于立新，等.血浆胆红素吸附治疗在肝移植围手术期的应用[J].天津医科大学学报，2007，13（3）：346
[2] Webb A N，Hardy P，Peterkin M，et al. Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: a blinded randomized trial[J]. Nutrition，2008，24（11-12）:1057
[3] Ren T，Cong L，Wang Y，et al. Lipid emulsions in parenteral nutrition: current applications and future developments[J]. Expert Opin Drug Deliv，2013，10：1533
[4] 何洁依，谢勇，陈蓉，等.肝硬化肝移植患者营养状况的调查[J].同济大学学报（医学版），2008，29（4）：128
[5] Anez-Bustillos L，Dao D T. Intravenous fat emulsion formulations for the adult and pediatric patient： understanding the differences[J].Nutr Clin Pract，2016，31：596
[6] Carpentier Y A，Dupont I E. Advances in intravenous lipid emulsions[J].World J Surg，2000，24：1493
[7] Hardy G，Puzovic M. Formulation，stability，and administration of parenteral nutrition with new lipid emulsions[J]. Nutr Clin Pract，2009，24（5）：616
[8] Turpin R，Canada T，Rosenthal V，et al. Bloodstream infections associated with parenteral nutrition preparation methods in the United States： a retrospective，large database analysis[J]. J Parenter Enteral Nutr，2012，36（2）:169
[9] Pontes-Arruda A，Zaloga G，Wischmeyer P，et al. Is there a difference in bloodstream infections in critically ill patients associated with ready-to-use versus compounded parenteral nutrition?[J]. Clin Nutr，2012，31（5）：728
[10] Berlana D，Sabin P，Gimeno-Ballester V，et al. Cost analysis of adult parenteral nutrition systems： three-compartment bag versus customized[J]. Nutr Hosp，2013，28（6）：2135
[11] Heidegger C P，Berger M M，Graf S，et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients：a randomised controlled clinical trial[J]. Lancet，2012，381：385
[12] Singh A，Chen M，Li T，et al. Parenteral nutrition combined with enteral nutrition for severe acute pancreatitis[J]. ISRN Gastroenterol，2012，2012：791383
[13] Jia Z，Yang J，Xia Y，et al. Safety and efficacy of an olive oil-based triple-chamber bag for parenteral nutrition： a prospective，randomized，multi-center clinical trial in China[J]. Nutr J，2015，14：119
[14] Wanten GJA.Parenteral lipids in nutritional support and immune modulation[J]. Clin Nutr Suppl，2009，4：13

相似文献/References:

[1]陈 环.肝癌介入治疗前后α2-抗纤溶酶、抗凝血酶Ⅲ、凝血因子Ⅷ检测的临床意义[J].天津医科大学学报,2014,20(04):327.
[2]郑 鹏,李 强.BCLC-B期肝细胞肝癌治疗效果分析[J].天津医科大学学报,2016,22(05):421.
　ZHENG Peng,LI Qiang.Analysis of therapeutic effect on patients with BCLC -B hepatocellular carcinoma[J].Journal of Tianjin Medical University,2016,22(04):421.
[3]侯振宇,孔银龙,孙 林,等.92例晚期肝细胞癌患者肝切除预后及危险因素分析[J].天津医科大学学报,2018,24(05):425.
　HOU Zhen-yu,KONG Yin-long,SUN Lin,et al.Prognosis and survival risk factors for 92 advanced hepatocellular carcinoma patients after hepatectomy[J].Journal of Tianjin Medical University,2018,24(04):425.
[4]廖诗晗,赵秀兰,张艳辉,等.LCMT1在肝癌中的表达和预后的意义[J].天津医科大学学报,2019,25(03):246.
　LIAO Shi-han,ZHAO Xiu-lan,ZHANG Yan-hui,et al.The expression and prognostic significance of LCMT1 in hepatocellular carcinoma[J].Journal of Tianjin Medical University,2019,25(04):246.
[5]张丽梅,贾莉莉 综 述,喻文立 审 校.外泌体在病毒性肝炎、肝硬化和肝癌中的作用研究进展[J].天津医科大学学报,2019,25(03):305.
[6]胡善雷,李广明,任 娜,等.GP73在HBV相关性肝病中的水平及意义[J].天津医科大学学报,2019,25(06):615.
　HU Shan-lei,LI Guang-ming,REN Na,et al.The level and significance of GP73 in HBV related liver diseases[J].Journal of Tianjin Medical University,2019,25(04):615.
[7]谢永丽,汤华.YTHDF1对HBV蛋白表达和HBsAg和HBeAg抗原分泌的作用[J].天津医科大学学报,2021,27(05):461.
　XIE Yong-li,TANG Hua.Role of YTHDF1 on HBV protein expression and secretion of HBsAg and HBeAg antigens[J].Journal of Tianjin Medical University,2021,27(04):461.
[8]赵冉,武燕洁,刘振凤,等.基于TCGA数据库分析JMJD6在肝癌组织中的表达及临床意义[J].天津医科大学学报,2022,28(01):15.
　ZHAO Ran,WU Yan-jie,LIU Zhen-feng,et al.The expression and clinical significance of JMJD6 in hepatocellular carcinoma based on TCGA database[J].Journal of Tianjin Medical University,2022,28(04):15.
[9]武燕洁,李譞媛,宣成昊,等.利用TCGA数据库分析MED19基因在肝癌中的表达及临床意义[J].天津医科大学学报,2022,28(04):383.
　WU Yan-jie,LI Xuan-yuan,XUAN Cheng-hao,et al.Analyze the expression and clinical significance of MED19 gene in hepatocellular carcinoma based on TCGA database[J].Journal of Tianjin Medical University,2022,28(04):383.
[10]罗焱瑞,赵倩.基于多组学Lasso回归分析构建肝癌预测模型[J].天津医科大学学报,2024,30(03):205.[doi:10.20135/j.issn.1006-8147.2024.03.0205]
　LUO Yanrui,ZHAO Qian.A liver cancer prediction model based on multi-omics Lasso regression analysis[J].Journal of Tianjin Medical University,2024,30(04):205.[doi:10.20135/j.issn.1006-8147.2024.03.0205]

备注/Memo

备注/Memo:

作者简介：陈莹（1981-），男，主治医师，硕士，研究方向：普通外科；通信作者：张雅敏，E-mail：zhangyamin@medmail.com.cn。

常用功能

更新日期/Last Update: 2021-07-25